Your browser is no longer supported. Please, upgrade your browser.
AXGN AxoGen, Inc. daily Stock Chart
AXGN [NASD]
AxoGen, Inc.
Index- P/E- EPS (ttm)-0.36 Insider Own1.80% Shs Outstand38.99M Perf Week3.74%
Market Cap2.00B Forward P/E- EPS next Y-0.20 Insider Trans-24.40% Shs Float37.03M Perf Month14.75%
Income-12.30M PEG- EPS next Q-0.09 Inst Own70.30% Short Float5.32% Perf Quarter30.83%
Sales65.40M P/S30.61 EPS this Y33.20% Inst Trans10.85% Short Ratio4.81 Perf Half Y83.07%
Book/sh0.63 P/B81.51 EPS next Y50.00% ROA-24.80% Target Price44.00 Perf Year235.62%
Cash/sh0.78 P/C65.43 EPS next 5Y- ROE-71.70% 52W Range14.30 - 53.95 Perf YTD81.45%
Dividend- P/FCF- EPS past 5Y18.10% ROI- 52W High-4.82% Beta0.03
Dividend %- Quick Ratio2.80 Sales past 5Y51.00% Gross Margin84.60% 52W Low259.09% ATR2.05
Employees199 Current Ratio3.30 Sales Q/Q41.80% Oper. Margin-14.80% RSI (14)66.83 Volatility4.52% 4.06%
OptionableYes Debt/Eq1.13 EPS Q/Q-43.40% Profit Margin-18.80% Rel Volume1.07 Prev Close51.75
ShortableYes LT Debt/Eq0.82 EarningsJul 30 AMC Payout- Avg Volume409.66K Price51.35
Recom1.50 SMA204.84% SMA5015.65% SMA20065.39% Volume438,752 Change-0.77%
Mar-02-18Reiterated Lake Street Buy $26 → $38
Jan-05-18Resumed Cantor Fitzgerald Overweight
Nov-30-17Initiated Jefferies Buy $35
Nov-21-17Reiterated Lake Street Buy $22 → $26
Jul-31-17Initiated Leerink Partners Outperform $22
Jun-30-17Initiated Cantor Fitzgerald Overweight $18
Mar-06-17Initiated ROTH Capital Buy $14.50
Nov-22-16Upgrade Lake Street Hold → Buy $9 → $11
Nov-07-16Reiterated Wedbush Outperform $10 → $12
Nov-03-16Downgrade Lake Street Buy → Hold $9
Aug-04-16Reiterated Wedbush Outperform $9 → $10
May-14-14Initiated Dawson James Buy $5
Oct-31-13Reiterated Ladenburg Thalmann Buy $4.50 → $5.75
Jun-08-18 11:50AM  AxoGen Chairman and CEO Karen Zaderej Named Entrepreneur Of The Year 2018 Award Winner in Florida GlobeNewswire
Jun-06-18 07:00AM  AxoGen, Inc. to Present at Upcoming Investor Conferences GlobeNewswire
Jun-04-18 07:40AM  Report: Developing Opportunities within Wix, AxoGen, YPF Sociedad Anonima, Orix Corp Ads, Travelport Worldwide, and Athene Holding Future Expectations, Projections Moving into 2018 GlobeNewswire
07:00AM  AxoGen, Inc. Appoints Kaila Krum Vice President, Investor Relations and Corporate Development GlobeNewswire
May-29-18 07:30AM  Complimentary Technical Snapshots on Avinger and Three More Medical Equipment Stocks ACCESSWIRE
07:00AM  AxoGen, Inc. Announces Repayment in Full of its $25 million Outstanding Debt GlobeNewswire
May-23-18 07:00AM  AxoGen, Inc. to Present at the Jefferies Global Healthcare Conference GlobeNewswire
May-21-18 07:01AM  AxoGen, Inc. Announces Appointment of Karen Zaderej as Chairman of the Board GlobeNewswire
May-14-18 07:00AM  AxoGen, Inc. Announces Closing of Public Offering of Common Stock GlobeNewswire
May-09-18 07:00AM  AxoGen, Inc. Announces Upsizing and Pricing of Public Offering of Common Stock GlobeNewswire
May-07-18 04:04PM  AxoGen Announces Proposed Public Offering of Common Stock GlobeNewswire
May-02-18 04:31AM  Edited Transcript of AXGN earnings conference call or presentation 30-Apr-18 8:30pm GMT Thomson Reuters StreetEvents
Apr-30-18 05:31PM  AxoGen: 1Q Earnings Snapshot Associated Press
04:05PM  AxoGen, Inc. Reports 2018 First Quarter Financial Results GlobeNewswire
12:30PM  AxoGen, Inc. to Host Earnings Call ACCESSWIRE
Apr-18-18 07:00AM  AxoGen, Inc. to Report First Quarter 2018 Financial Results and Host Conference Call on April 30, 2018 GlobeNewswire
Apr-12-18 07:00AM  AxoGen, Inc. Announces 2018 Annual Shareholders Meeting GlobeNewswire
Apr-10-18 07:55AM  Factors of Influence in 2018, Key Indicators and Opportunity within Randgold Resources, GasLog Partners LP, Mountain Province Diamonds, NEXEO SOLUTIONS, AxoGen, and Silicon Motion Technology New Research Emphasizes Economic Growth GlobeNewswire
Mar-27-18 12:22PM  AxoGen (AXGN) Enters Overbought Territory Zacks
Mar-23-18 07:30AM  Biotricity: A Little Known Stock That Could Be The Next AXGN or EXAS ACCESSWIRE
Mar-14-18 07:55AM  Research Report Identifies China Tel, Eaton Corporation, Ctrip.com International, AxoGen, Athene Holding, and Intuitive Surgical with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Mar-07-18 07:20AM  Blog Exposure - Boston Scientific Acquired EMcision for Undisclosed Amount ACCESSWIRE
Mar-05-18 11:07AM  Are Earnings Prospects Improving For Loss-Making AxoGen Incs (NASDAQ:AXGN)? Simply Wall St.
Mar-02-18 12:32PM  AxoGen (AXGN) Q4 2017 Earnings Conference Call Transcript Motley Fool
12:11AM  Edited Transcript of AXGN earnings conference call or presentation 28-Feb-18 9:30pm GMT Thomson Reuters StreetEvents
Feb-28-18 05:03PM  AxoGen reports 4Q loss Associated Press -6.41%
04:01PM  AxoGen, Inc. Reports 2017 Fourth Quarter and Full Year Financial Results GlobeNewswire
12:00PM  AxoGen, Inc. to Host Earnings Call ACCESSWIRE
Feb-27-18 07:10AM  AxoGen Named Employee Engagement Best Practices Award Winner by DecisionWise International GlobeNewswire +5.76%
07:00AM  AxoGen, Inc. to Present at 30th Annual ROTH Conference GlobeNewswire
Feb-20-18 07:00AM  AxoGen, Inc. to Present at Canaccord Genuity Musculoskeletal Conference GlobeNewswire
Feb-18-18 11:02AM  Best Growth Stock in February Simply Wall St.
Feb-14-18 07:00AM  AxoGen, Inc. to Report Fourth Quarter and Full-Year 2017 Financial Results and Host Conference Call on February 28, 2018 GlobeNewswire
Feb-05-18 04:31PM  William Blair's Got Nerve: Initiates AxoGen Coverage With Outperform Benzinga
Feb-01-18 07:00AM  AxoGen, Inc. to Present at the LEERINK Partners 7th Annual Global Healthcare Conference GlobeNewswire
Jan-17-18 11:02AM  Top 3 Growth Stocks For The Month Simply Wall St.
Jan-08-18 07:00AM  AxoGen, Inc. Preannounces Estimated Fourth Quarter and Full Year 2017 Revenue GlobeNewswire -5.31%
Jan-05-18 07:00AM  AxoGen to Participate at AAHS ASPN ASRM 2018 Annual Meetings GlobeNewswire +8.38%
Dec-29-17 11:32AM  ETFs with exposure to AxoGen, Inc. : December 29, 2017 Capital Cube
Dec-18-17 02:41PM  ETFs with exposure to AxoGen, Inc. : December 18, 2017 Capital Cube
07:00AM  AxoGen Corporation Announces Avance® Nerve Graft Recipient Selected to Ride on Donate Life Rose Parade® Float GlobeNewswire
Dec-17-17 11:02AM  December Top Growth Stocks To Look Out For Simply Wall St.
Dec-01-17 10:26AM  ETFs with exposure to AxoGen, Inc. : December 1, 2017 Capital Cube
Nov-30-17 07:25PM  Edited Transcript of AXGN earnings conference call or presentation 1-Nov-17 8:30pm GMT Thomson Reuters StreetEvents
Nov-20-17 11:15AM  AxoGen Announces Closing of Public Offering of Common Stock GlobeNewswire
10:00AM  AxoGen, Inc. (Nasdaq: AXGN) to Ring The Nasdaq Stock Market Opening Bell GlobeNewswire
08:00AM  AxoGen Advances its Platform for Nerve Repair at Annual Analyst and Investor Day GlobeNewswire
Nov-16-17 11:12AM  ETFs with exposure to AxoGen, Inc. : November 16, 2017 Capital Cube -9.24%
11:02AM  November Growth Stocks To Look Out For Simply Wall St.
08:40AM  AxoGen, Inc. Announces Pricing of Public Offering of Common Stock GlobeNewswire
Nov-15-17 04:43PM  AxoGen, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire
Nov-14-17 07:00AM  AxoGen, Inc. to Present at the 29th Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-07-17 07:00AM  AxoGen to Host Second Annual Analyst and Investor Day on November 20, 2017 GlobeNewswire
Nov-06-17 11:08AM  ETFs with exposure to AxoGen, Inc. : November 6, 2017 Capital Cube
Nov-03-17 10:03AM  AxoGen, Inc. :AXGN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017 Capital Cube +7.91%
Nov-01-17 06:45PM  AxoGen reports 3Q loss Associated Press
04:05PM  AxoGen, Inc. Reports 2017 Third Quarter Financial Results GlobeNewswire
Oct-31-17 12:35PM  Is AxoGen Inc (AXGN) A Financially Sound Company? Simply Wall St.
Oct-25-17 09:51AM  ETFs with exposure to AxoGen, Inc. : October 25, 2017 Capital Cube
Oct-18-17 07:00AM  AxoGen, Inc. Receives David J. Gury Company of the Year Award from BioFlorida GlobeNewswire
Oct-17-17 07:00AM  AxoGen, Inc. to Report Third Quarter 2017 Financial Results and Host Conference Call on November 1, 2017 GlobeNewswire
Oct-13-17 10:31AM  ETFs with exposure to AxoGen, Inc. : October 13, 2017 Capital Cube
Oct-02-17 10:41AM  ETFs with exposure to AxoGen, Inc. : October 2, 2017 Capital Cube
07:00AM  AxoGen to Participate at 99th Annual American Association of Oral and Maxillofacial Surgeons Meeting GlobeNewswire
Sep-22-17 10:16AM  ETFs with exposure to AxoGen, Inc. : September 22, 2017 Capital Cube
Sep-11-17 09:19PM  ETFs with exposure to AxoGen, Inc. : September 12, 2017 Capital Cube
07:00AM  AxoGen, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-08-17 05:23PM  AxoGen, Inc. :AXGN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 8, 2017 Capital Cube
Aug-25-17 04:10PM  Edited Transcript of AXGN earnings conference call or presentation 2-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-24-17 07:00AM  AxoGen to Participate at 72nd Annual American Society for Surgery of the Hand Meeting GlobeNewswire
Aug-15-17 09:08AM  AxoGen, Inc. breached its 50 day moving average in a Bullish Manner : AXGN-US : August 15, 2017 Capital Cube
Aug-11-17 07:36PM  AxoGen, Inc. Value Analysis (NASDAQ:AXGN) : August 11, 2017 Capital Cube
Aug-02-17 10:46PM  AxoGen reports 2Q loss Associated Press
04:01PM  AxoGen, Inc. Reports 2017 Second Quarter Financial Results GlobeNewswire
10:50AM  Investor Network: AxoGen, Inc. to Host Earnings Call ACCESSWIRE
Jul-31-17 07:00AM  AxoGen, Inc. to Present at the Wedbush PacGrow Healthcare Conference GlobeNewswire
Jul-28-17 09:32AM  AxoGen, Inc. breached its 50 day moving average in a Bearish Manner : AXGN-US : July 28, 2017 Capital Cube
Jul-20-17 05:00PM  AxoGen, Inc. Discloses Terms of Recent Equity Award GlobeNewswire
Jul-19-17 07:00AM  AxoGen, Inc. to Report Second Quarter 2017 Financial Results and Host Conference Call on Wednesday, August 2, 2017 GlobeNewswire
Jul-17-17 07:00AM  AxoGen, Inc. Appoints Jon Gingrich Chief Commercial Officer GlobeNewswire
Jun-08-17 01:24PM  ETFs with exposure to AxoGen, Inc. : June 8, 2017 Capital Cube
Jun-07-17 07:00AM  AxoGen, Inc. to Present at the JMP Securities Life Sciences Conference GlobeNewswire
May-23-17 07:00AM  AxoGen, Inc. to Present at the Jefferies Global Healthcare Conference GlobeNewswire
May-22-17 08:20AM  AxoGen (AXGN) Shows Strength: Stock Adds 6.1% in Session Zacks
May-15-17 03:19PM  ETFs with exposure to AxoGen, Inc. : May 15, 2017 Capital Cube
May-10-17 11:18AM  AxoGen, Inc. :AXGN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017 Capital Cube
May-04-17 07:09PM  AxoGen reports 1Q loss Associated Press
04:02PM  AxoGen, Inc. Reports 2017 First Quarter Financial Results GlobeNewswire
10:00AM  Investor Network: AxoGen, Inc. to Host Earnings Call Accesswire
May-02-17 03:43PM  ETFs with exposure to AxoGen, Inc. : May 2, 2017 Capital Cube
Apr-17-17 12:47PM  ETFs with exposure to AxoGen, Inc. : April 17, 2017 Capital Cube
Apr-14-17 07:00AM  AxoGen, Inc. to Report First Quarter 2017 Financial Results and Host Conference Call on Thursday, May 4, 2017 GlobeNewswire
Apr-11-17 07:12PM  Cramer Remix: Why a slew of IPOs might not be a good thin... CNBC Videos
Apr-07-17 08:30AM  AxoGen, Inc. Announces 2017 Annual Shareholders Meeting GlobeNewswire
Apr-05-17 04:22PM  ETFs with exposure to AxoGen, Inc. : April 5, 2017 Capital Cube
Apr-03-17 08:17AM  AxoGen, Inc. breached its 50 day moving average in a Bullish Manner : AXGN-US : April 3, 2017 Capital Cube
Mar-17-17 12:08PM  AxoGen, Inc. :AXGN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017 Capital Cube
Mar-10-17 01:43PM  AxoGen, Inc. :AXGN-US: Earnings Analysis: 2016 By the Numbers : March 10, 2017 Capital Cube
Mar-07-17 01:04PM  AXOGEN, INC. Financials
07:00AM  AxoGen, Inc. to Present at the Oppenheimer 27th Annual Healthcare Conference GlobeNewswire
AxoGen, Inc. develops and markets surgical solutions for peripheral nerve injuries. The company's surgical solutions include Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its solutions also comprise Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues and modulate inflammation in the surgical bed. In addition, the company offers AcroVal neurosensory and motor testing system, which consists of AcroGrip for use in hand grip strength measurement; AcroPinch for measuring pinch strength; and Pressure-Specified Sensory Device, a somatosensory evaluation and measurement device. Further, it provides AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals in the United States, Canada, the United Kingdom and other European countries, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rudelius Robert JamesDirectorJun 08Option Exercise2.7512,00033,00035,273Jun 12 04:42 PM
Gold Mark StephenDirectorJun 01Option Exercise14.8515,000222,750375,248Jun 05 05:02 PM
MCCARREY SHAWN FSVP SalesMay 16Sale43.4710,000434,70033,057May 18 06:25 PM
Donovan Michael PatrickVP OperationsMar 26Option Exercise2.7430,00082,20039,659Mar 27 06:45 PM
Hansen David KVP Finance & TreasurerMar 22Option Exercise2.7436,500100,02544,821Mar 26 06:13 PM
Freitag Gregory GeneGeneral Counsel & SVP BDMar 21Option Exercise3.6031,000111,510162,739Mar 23 08:44 AM
Freitag Gregory GeneGeneral Counsel & SVP BDMar 01Option Exercise2.7436,00098,640135,666Mar 05 05:27 PM
Grooms Jamie MarkDirectorFeb 21Sale28.4057,4061,630,330372Feb 23 07:08 PM
Grooms Jamie MarkDirectorFeb 20Sale27.9036,7401,025,04662,861Feb 20 07:52 PM
Grooms Jamie MarkDirectorFeb 16Sale27.3526,655729,01499,601Feb 20 07:52 PM
Grooms Jamie MarkVP, CFOFeb 15Sale27.1143,4031,176,655126,256Feb 15 07:56 PM
Grooms Jamie MarkVP, CFOFeb 14Sale26.7242,0091,122,3900Feb 15 07:56 PM
Grooms Jamie MarkVP, CFOFeb 13Sale26.2110,300269,9249,073Feb 15 07:56 PM
Grooms Jamie MarkDirectorDec 12Sale26.3416,585436,849240,607Dec 13 07:45 PM
Grooms Jamie MarkDirectorDec 11Sale26.3521,820574,957257,192Dec 13 07:45 PM
Grooms Jamie MarkDirectorDec 08Sale26.3731,805838,698281,312Dec 08 06:30 PM
Grooms Jamie MarkDirectorDec 07Sale26.5031,200826,800313,117Dec 08 06:30 PM
Grooms Jamie MarkDirectorDec 06Sale26.2221,290558,224344,317Dec 08 06:30 PM
NEELS GUIDO JDirectorNov 20Sale19.741,150,00022,701,0003,371,111Nov 21 03:31 PM
Essex Woodlands Fund IX, L.P.10% OwnerNov 20Sale19.741,150,00022,701,0003,711,111Nov 21 03:31 PM
Gold Mark StephenDirectorNov 13Option Exercise5.0915,00076,350360,248Nov 15 11:22 AM
Grooms Jamie MarkDirectorNov 01Option Exercise0.2714,3793,882365,796Nov 03 04:56 PM
Friedman Mark LouisVP,Regulatory & QualityOct 24Option Exercise2.5867,767174,96267,952Oct 26 05:04 PM
Freitag Gregory GeneGeneral Counsel & SVP BDSep 25Option Exercise2.7410,00027,400101,116Sep 27 05:22 PM
Rudelius Robert JamesDirectorSep 11Sale18.0016,143290,57423,273Sep 12 04:02 PM
Rudelius Robert JamesDirectorSep 08Option Exercise3.5020,00070,00043,273Sep 12 04:02 PM
Freitag Gregory GeneGeneral Counsel & SVP BDAug 27Option Exercise2.7423,00063,02094,901Aug 29 04:58 PM